Phase 1 results of PTC596, a novel small molecule targeting cancer stem cells (CSCs) by reducing levels of BMI1 protein
-
- Laskin
- 作成者
収録刊行物
-
- J Clin Oncol
-
J Clin Oncol 35-, 2017